Stem Cell Research & Therapy · 2019 · 35 citations · 35 references
MedicineBiotechnologyMolecular MedicineAgingRegenerative MedicineStem Cell TransplantationErectile DysfunctionMesenchymal Stem Cell TherapyMesenchymal Stromal Cell TherapyMicrorna BiologyMicrorna-mediated RegulationTissue Engineering With Stem CellsBone Marrow - Derived CellsBone Marrow Mesenchymal Stem CellsBone Marrow-derived Mesenchymal Stromal CellsDual-luciferase AssaysErectile Function RestorationMicrorna TherapeuticsMicrorna TherapyWestern Blot Analysis
BACKGROUND: Aging is one of the dominant factors contributing to erectile dysfunction (ED), and effective treatments for age-associated ED are urgently demanded. In this study, the therapeutic efficiency of bone marrow-derived mesenchymal stem cells (BMSCs) overexpressing microRNA-145 (miR-145) was evaluated in ED. METHODS: Sixty male Sprague-Dawley rats (24 months old) were randomly divided into 4 treatment groups (n = 15/group): PBS (control), BMSCs, BMSCs transfected with a blank vector (vector-BMSCs), and BMSCs transfected with a lentivirus overexpressing miR-145 (OE-miR-145-BMSCs). Fourteen days after transplantation of BMSCs, erectile function was evaluated by measuring intra-cavernous pressure (ICP) and mean arterial pressure (MAP). Subsequently, penile erectile tissues were harvested and subjected to Masson staining, qRT-PCR, immunofluorescence staining, dual luciferase assay, and Western blot analysis. RESULTS: Fourteen days after transplantation, the ICP/MAP was 0.79 ± 0.05 in the OE-miR-145-BMSC group, 0.61 ± 0.06 in the BMSC group, 0.57 ± 0.06 in the vector-BMSC group, and 0.3 ± 0.01 in the PBS group. Treatment with OE-miR-145-BMSCs significantly improved ED (P < 0.05), and the treatment increased the smooth muscle content in the penis tissues of ED rats (P < 0.05). In the OE-miR-145-BMSC group, the expression levels of α-SMA, desmin, and SM-MHC were higher than they were in the other ED groups (P < 0.05). In addition, the levels of collagen 1, MMP2, and p-Smad2 in the BMSC-treated group, especially in the OE-miR-145-BMSC group, were lower than those in the control group (P < 0.05). CONCLUSIONS: MicroRNA-145 engineered BMSCs effectively attenuate age-related ED. Transplantation of miR-145-overexpressing BMSCs may provide a promising novel avenue for age-associated ED therapy.
35
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity
Kimberly R. Cordes, Neil T. Sheehy, Mark P. White et al. · Nature · 2009 · 1.6K citations · Full text
MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells
Na Xu, Thales Papagiannakopoulos, Guangjin Pan et al. · Cell · 2009 · 1.1K citations · Full text
Leonardo Elia, Manuela Quintavalle, Jiajun Zhang et al. · Cell Death and Differentiation · 2009 · 570 citations